Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
TGR-1202 and Ibrutinib in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT02874404. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)
ClinicalTrials.gov study NCT01030536. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia
ClinicalTrials.gov study NCT01515176. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of ET019002-T Cell Therapy for Refractory/Relapsed B-Cell Malignancies
ClinicalTrials.gov study NCT03642496. IPD Sharing: NO. Countries: 0. Publications: 1.
TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, R
ClinicalTrials.gov study NCT03615144. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Induction and Maintenance Treatment With MabThera (Rituximab) in Patients With Indolent B-Cell Nonfollicular Lymphomas
ClinicalTrials.gov study NCT01153971. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory Diffuse Large b Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT01120834. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies
ClinicalTrials.gov study NCT03151057. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
ClinicalTrials.gov study NCT05940272. IPD Sharing: YES. Countries: 1. Publications: 0.
Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00863369. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT07400029. IPD Sharing: YES. Countries: 1. Publications: 0.
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular Lymphoma
ClinicalTrials.gov study NCT03571828. IPD Sharing: YES. Countries: 4. Publications: 0.
Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT01278615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)
ClinicalTrials.gov study NCT04875195. IPD Sharing: YES. Countries: 11. Publications: 0.
Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
ClinicalTrials.gov study NCT02433795. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission
ClinicalTrials.gov study NCT02530125. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metformin Reduce the Relapse Rate on Patients With B-cell Precursor (Ph+ Negative) Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT03118128. IPD Sharing: Not stated. Countries: 0. Publications: 3.
A Study to Evaluate the Safety and Efficacy of Dasatinib (Sprycel) in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT00918463. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02594163. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03019640. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.